J. Molner AS Logo

J. Molner AS

ISIN

EE3100109034

Ticker

JML

Sector

Health Care

Sub-Industry

Pharmaceuticals

Country

Estonia

Year Founded

2020

About J. Molner AS

Company Description

Located in Northern Europe in Estonia, The J. Molner Company's main laboratory was originally founded in 2015 as part of a global pharmaceutical company to accelerate research and development activities. With a focus on sterile injectable and dermatological drugs for both the United States and Canada, our team has developed a GMP certified facility that provides services to pharmaceutical companies looking to grow their pipelines and manage costs by leveraging our capabilities.

Served Area

Worldwide

Headquarters

Akadeemia tee 21/5
12618, Tallinn
Estonia

Capital Markets Information

ISIN

EE3100109034

LEI

984500F0KEF52E642E45

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

Nasdaq Baltic

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.